论文部分内容阅读
目的:为探讨ET—1在高原地区及急进特高海拔地区的变化及其对急慢性高原病的意义;方法:对20名健康战士在高原(3658m)和急进特高海拔(4700m)后的血浆ET—1水平进行检测,同时检测了两地的血氧饱和度(SaO2);结果而原地区的ET—1水平明显高于平原参考值(P<0.05),急进海拔4700m后EF-1水平更显著的增高(P<0.01),且与SaO2呈明显负相关(P<0.01,r=0.628)。结论:在高原地区及急进特高海拔后ET—1水平皆增高,FT—1水平的增高是急慢性高原病发病的重要因素。
Objective: To investigate the changes of ET-1 in the plateau area and the areas of rapidly rising high altitude and its significance for acute and chronic altitude sickness.METHODS: Twenty healthy warfighters were enrolled in this study after being exposed to high altitude (3658m) and rapid extra-high altitude (4700m) The level of ET-1 in plasma and plasma oxygen saturation (SaO2) were measured at the same time. As a result, the level of ET-1 in the original area was significantly higher than that of plain reference (P <0.05) -1 significantly (P <0.01), and negatively correlated with SaO2 (P <0.01, r = 0.628). CONCLUSION: ET-1 levels are elevated in the plateau area and in the emergent and extra-high altitude. The increase of FT-1 level is an important factor in the pathogenesis of acute and chronic altitude sickness.